Cargando…
Cost of illness and economic burden of chronic lymphocytic leukemia
BACKGROUND: Chronic lymphocytic leukemia (CLL) is a slowly progressing but fatal disease that imposes a high economic burden on sickness funds and society. The objective of this study was to analyze and compare the direct and indirect costs of CLL in Germany from the perspective of the sickness fund...
Autores principales: | Blankart, Carl Rudolf, Koch, Taika, Linder, Roland, Verheyen, Frank, Schreyögg, Jonas, Stargardt, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598307/ https://www.ncbi.nlm.nih.gov/pubmed/23425552 http://dx.doi.org/10.1186/1750-1172-8-32 |
Ejemplares similares
-
An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals
por: Meggiolaro, Angela, et al.
Publicado: (2022) -
The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study
por: Achelrod, Dmitrij, et al.
Publicado: (2014) -
The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
por: Schreyögg, Jonas, et al.
Publicado: (2010) -
Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort
por: Achelrod, Dmitrij, et al.
Publicado: (2016) -
Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany: Methodologies and criteria
por: Busse, Reinhard, et al.
Publicado: (2005)